SELL YOUR PRODUCTS
*mymedicalexpo  
English

COVID-19 rapid test SCREEN COVID-19+FLU A/B
SARS-COV-2coronavirusinfluenza B

COVID-19 rapid test
COVID-19 rapid test
Add to favorites
Compare this product
 

Characteristics

Applications
COVID-19
Micro-organism
SARS-COV-2, coronavirus, influenza B, influenza A
Sample type
nasopharyngeal
Analysis mode
immunochromatographic, immunochemical

Description

SCREEN TEST COVID-19+FLU A/B Covid-19 and Influenza A+B Antigen Combo Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of Sars-CoV-2, Influenza A and Influenza B virus antigens present in human nasopharynx. For professional in vitro diagnostic use only. The Covid-19 and Influenza A+B Antigen Combo Rapid Test (Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of Sars-CoV-2, Influenza A and Influenza B virus antigens in nasopharyngeal swab specimens. Results are for the detection of Sars-CoV-2 and Influenza A+B Antigens. An antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.

Other Screen Italia Srl products

Infectious Diseases

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.